End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
92.8 TWD | -0.85% | -5.21% | -12.04% |
05-02 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
ETFs positioned on PharmaEngine, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.59% | - | |
0.00% | 34 M€ | +4.20% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.04% | 417M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 4162 Stock
- Funds and ETFs PharmaEngine, Inc.